China · Delayed Price · Currency is CNY Cisen Pharmaceutical Statistics
Total Valuation
SHA:603367 has a market cap or net worth of CNY 6.58 billion. The enterprise value is 2.62 billion.
| Market Cap | 6.58B |
| Enterprise Value | 2.62B |
Important Dates
The next confirmed earnings date is Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Sep 16, 2026 |
Share Statistics
SHA:603367 has 452.75 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Current Share Class | 452.75M |
| Shares Outstanding | 452.75M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | +2.25% |
| Owned by Insiders (%) | 6.59% |
| Owned by Institutions (%) | 4.50% |
| Float | 205.26M |
Valuation Ratios
The trailing PE ratio is 14.52.
| PE Ratio | 14.52 |
| Forward PE | n/a |
| PS Ratio | 1.94 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | 12.88 |
| P/OCF Ratio | 12.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.00, with an EV/FCF ratio of 5.13.
| EV / Earnings | 5.74 |
| EV / Sales | 0.77 |
| EV / EBITDA | 6.00 |
| EV / EBIT | 11.59 |
| EV / FCF | 5.13 |
Financial Position
The company has a current ratio of 4.53, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.53 |
| Quick Ratio | 3.94 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.06 |
| Interest Coverage | 260.42 |
Financial Efficiency
Return on equity (ROE) is 7.35% and return on invested capital (ROIC) is 7.67%.
| Return on Equity (ROE) | 7.35% |
| Return on Assets (ROA) | 1.83% |
| Return on Invested Capital (ROIC) | 7.67% |
| Return on Capital Employed (ROCE) | 3.45% |
| Weighted Average Cost of Capital (WACC) | 5.07% |
| Revenue Per Employee | 1.09M |
| Profits Per Employee | 146,605 |
| Employee Count | 3,114 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.54 |
Taxes
In the past 12 months, SHA:603367 has paid 63.76 million in taxes.
| Income Tax | 63.76M |
| Effective Tax Rate | 12.14% |
Stock Price Statistics
The stock price has decreased by -28.81% in the last 52 weeks. The beta is 0.15, so SHA:603367's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -28.81% |
| 50-Day Moving Average | 14.48 |
| 200-Day Moving Average | 15.67 |
| Relative Strength Index (RSI) | 52.86 |
| Average Volume (20 Days) | 5,658,327 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603367 had revenue of CNY 3.40 billion and earned 456.53 million in profits. Earnings per share was 1.00.
| Revenue | 3.40B |
| Gross Profit | 1.67B |
| Operating Income | 225.93M |
| Pretax Income | 525.05M |
| Net Income | 456.53M |
| EBITDA | 434.29M |
| EBIT | 225.93M |
| Earnings Per Share (EPS) | 1.00 |
Balance Sheet
The company has 4.03 billion in cash and 32.84 million in debt, with a net cash position of 4.00 billion or 8.84 per share.
| Cash & Cash Equivalents | 4.03B |
| Total Debt | 32.84M |
| Net Cash | 4.00B |
| Net Cash Per Share | 8.84 |
| Equity (Book Value) | 6.42B |
| Book Value Per Share | 14.10 |
| Working Capital | 4.51B |
Cash Flow
In the last 12 months, operating cash flow was 540.15 million and capital expenditures -29.27 million, giving a free cash flow of 510.88 million.
| Operating Cash Flow | 540.15M |
| Capital Expenditures | -29.27M |
| Depreciation & Amortization | 208.36M |
| Net Borrowing | -1.35M |
| Free Cash Flow | 510.88M |
| FCF Per Share | 1.13 |
Margins
Gross margin is 49.02%, with operating and profit margins of 6.65% and 13.43%.
| Gross Margin | 49.02% |
| Operating Margin | 6.65% |
| Pretax Margin | 15.45% |
| Profit Margin | 13.43% |
| EBITDA Margin | 12.78% |
| EBIT Margin | 6.65% |
| FCF Margin | 15.03% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 2.20%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 2.20% |
| Dividend Growth (YoY) | -7.84% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 34.12% |
| FCF Payout Ratio | 33.32% |
| Buyback Yield | -0.55% |
| Shareholder Yield | 1.66% |
| Earnings Yield | 6.94% |
| FCF Yield | 7.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603367 has an Altman Z-Score of 5.59 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.59 |
| Piotroski F-Score | 5 |